A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health.


Updates from The Motley Fool

Latest updates on Merck & Co. from Fool.com.  The Fool has written over 1600 articles on Merck & Co..
Is Merck & Co. a Buy?

Merck's massive surge higher might be coming to an end. Here's why.



Stock Performance

View Interactive MRK Charts
Sponsored by

Key Data Points

Primary metrics and data points about Merck & Co..
Current Price: $74.71
Prev Close: $74.86
Open: $75.13
Bid: $74.75
Ask: $74.76
Day's Range: $74.03 - $75.27
52wk Range: $52.83 - $75.99
Volume: 8,951,319
Avg Vol 12,520,602
Market Cap: $204B
P/E (ttm): 59.89
EPS (ttm): $1.25
Div & Yield: $1.92 (2.9%)

Company Rating

What our community thinks about Merck & Co..
CAPS Rating 4 out of 5
 
2712 Outperform
219 Underperform
CAPS All Stars
 
618 Outperform
34 Underperform

How do you think Merck & Co. will perform against the market?



You pick for Merck & Co. is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Kenneth C. Frazier, CEO

82% Approve

Based on 1029 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Merck & Co..

A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health.

  • Exchange: NYSE
  • Sector: Healthcare
  • Industry: Drug Makers